DSpace at RU >

Browsing by Author Lems, W.F.

Full Text	Issue Date	Title	Author(s)
	2012	Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis.	Lent, P.L.E.M. van; Blom, A.B.; Schelbergen, R.F.P.; Sloetjes, A.W.; Lafeber, F.P.J.G., et al
	2012	Esomeprazole relieves upper gastrointestinal symptoms in high-risk and average-risk NSAID users in daily clinical practice: results from an open-label study.	Tielemans, M.M.; Oijen, M.G.H. van; Mulder, C.J.; Vos, K.J.; Lems, W.F.
	2009	Richtlijn ‘Diagnostiek en behandeling van reumatoïde artritis’	Schipper, L.G.; Hoekstra, M.O.; Vliet Vlieland, T.P.M.; Jansen, T.L.Th.A.; Lems, W.F., et al
	2008	Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT study.	Jong, Z de; Munneke, M.; Vilim, V.; Zwinderman, A.H.; Kroon, H.M., et al
	2007	Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.	Jacobs, J.W.; Nijs, R.N. de; Lems, W.F.; Geusens, P.P.; Laan, R.F.J.M., et al
	2007	[Alendronate more effective than alfacalcidol in the prevention of osteoporosis in patients with rheumatic disease who are starting glucocorticoid therapy]	Nijs, R.N. de; Jacobs, J.W.; Lems, W.F.; Laan, R.F.J.M.; Algra, A., et al
	2006	Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.	Nijs, R.N. de; Jacobs, J.W.; Lems, W.F.; Laan, R.F.J.M.; Algra, A., et al
	2004	Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial.	Jong, Z. de; Munneke, M.; Lems, W.F.; Zwinderman, A.H.; Kroon, H.M., et al
	2004	Long term high intensity exercise and damage of small joints in rheumatoid arthritis.	Jong, Z. de; Munneke, M.; Zwinderman, A.H.; Kroon, H.M.; Ronday, K.H., et al